Cocrystal Pharma, Inc. (COCP) financial statements and ratios from SEC XBRL: revenue $2.01M (TTM), net margin -479.0%. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $2.01M |
| Net Margin | -479.0% |
| Price / Book | 20.94 |
| Price / Sales | 20.76 |
| FCF Yield | -29.6% |
| Sector P/E (Healthcare) | 21.7 |
COCP overview · COCP earnings · COCP KPIs · COCP investor relations · COCP ownership · COCP peers · COCP filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.